SO
RVMD icon

STRS Ohio’s Revolution Medicines RVMD Stock Holding History

STRS Ohio’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
54,428
+50,360
+1,238% +$7.36M 0.04% 379
2026
Q1 		$396K Sell
4,068
-83
-2% -$8.38K ﹤0.01% 1203
2025
Q4 		$331K Buy
4,151
+7
+0.2% +$459 ﹤0.01% 1276
2025
Q3 		$194K Buy
4,144
+2
+0% +$78 ﹤0.01% 1558
2025
Q2 		$152K Sell
4,142
-15,258
-79% -$586K ﹤0.01% 1748
2025
Q1 		$686K Hold
19,400
– – ﹤0.01% 1009
2024
Q4 		$849K Buy
19,400
+2,800
+17% +$141K ﹤0.01% 910
2024
Q3 		$753K Hold
16,600
– – ﹤0.01% 1019
2024
Q2 		$644K Buy
16,600
+5,600
+51% +$209K ﹤0.01% 1062
2024
Q1 		$354K Buy
11,000
+1,300
+13% +$38.5K ﹤0.01% 1381
2023
Q4 		$278K Buy
9,700
+3,400
+54% +$81.7K ﹤0.01% 1475
2023
Q3 		$174K Buy
6,300
+4,600
+271% +$136K ﹤0.01% 1598
2023
Q2 		$45K Buy
+1,700
New +$41.7K ﹤0.01% 1820
2021
Q1 		– Sell
-300
Closed -$11K – 2267
2020
Q4 		$11K Sell
300
-3,600
-92% -$142K ﹤0.01% 2105
2020
Q3 		$135K Hold
3,900
– – ﹤0.01% 1766
2020
Q2 		$123K Buy
3,900
+300
+8% +$9.43K ﹤0.01% 1750
2020
Q1 		$78K Buy
+3,600
New +$99.7K ﹤0.01% 1720

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

STRS Ohio's RVMD Position: Q2 2026 in Review

STRS Ohio increased its Revolution Medicines (RVMD) stake by 1,238% in Q2 2026, buying an estimated $7.36M and bringing the position to 54,428 shares worth $10.2M. The position accounts for 0.04% of the portfolio, ranked #379.

STRS Ohio first reported a position in RVMD in Q1 2020 and has held it in 17 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • STRS Ohio held 54,428 shares of Revolution Medicines worth $10.2M as of Q2 2026.
  • STRS Ohio bought 50,360 Revolution Medicines shares in Q2 2026, an estimated $7.36M.
  • Revolution Medicines made up 0.04% of STRS Ohio's portfolio in Q2 2026, its #379 holding.
  • STRS Ohio first reported a position in Revolution Medicines in Q1 2020 and has held it in 17 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.